The possibility of using in vitro testing to determine the equivalence of risk for various occupational groups is discussed. In the absence of epidemiological evidence or relevant animal in vivo bioassays on which to determine the health effects of specific occupational exposures, it is proposed to use similarities in the in vitro response to substances with known (or strongly suspected) and unknown risk to demonstrate their risk equivalence. Identification and evaluation of a high risk "hot spot" due to exposure to Cr(VI) for stainless steel welders is discussed in terms of recent developments in collection, analysis and bioassay of welding fumes.
Introduction
Assessment of health risk due to occupation is difficult in a number of industries where many workers are exposed to wide and varying ranges of potentially toxic substances, especially where delayed health effects such as emphysema and respiratory tract cancer appear only towards or at the end of a long working career, frequently after the critical exposure has ceased. It would be extremely useful to demonstrate that appropriate in vitro screening tests could be used in quantitatively assessing health risks associated with some occupational exposures. In the absence of a methodology to estimate risk independently, it would be equally useful to be able to utilize such tests in a semiquantitative fashion to rank in order of biological activity various exposures of alternative technologies. This would permit a reduction of otherwise unquantified risk by replacement of suspected processes with those which were technologically equivalent but which produce exposures of demonstrably reduced biological activity. An alternative approach would be the assessment of equivalent risk whereby exposures in one industry could be demonstrated to produce an in vitro response identical or similar to those for comparable substances found in industries where the associated human risk was known. The results of preliminary attempts to use such an approach in the welding industry are described below.
The process of welding, a technology in which 1-2% of the work force is engaged in the industrial-*The Danish Welding Institute, DK-2600 Glostrup, Denmark.
ized countries, produces fume concentrations of the order of 100-400 mg/m3 in the rising column of heated air directly above the arc. Average breathing zone concentrations depend to a great extent on the technology used, but levels of 5 mg/m3 are currently typical throughout the industry (1, 2).
The extremely wide range of technologies, e.g., manual metal arc (MMA) and metal inert gas (MIG), and their applications to various base materials such as aluminum (AL), mild steel (MS), and stainless steel (SS) creates an extraordinary variety of exposures to over 20 different metals, their alloys and oxides, although a few specific combinations of process and materials do provide several well-defined cohorts with specific process-dependent exposures which lie within relatively narrow ranges (1, 2) .
While the presence of high concentrations of certain toxic substances-e.g., NO2, 03, Cd-in welding fumes can be related to the risk of acute toxicity in some exposures, the question of whether or not welders suffer an average overincidence of various pneumoconioses (or other delayed health effects) remains unresolved. Wide variations in intergroup incidence, e.g., of small round opacities and of chronic bronchitis, are found in cross-sectional studies (1) , and the effects of smoking and population dynamics apparently mask the effect of welding on lung function (U4). Over 90 cases of pulmonary fibrosis among welders have been identified (5) , although the incidence rate among welders or of the normal population is unknown.
On the other hand, five recent epidemiological studies of large general welding populations (6) (7) (8) (9) (10) indicate a statistically significant overincidence of respiratory tract cancer (and together show a total of 417 observed compared to 307 expected cases in 420,000 man years). However, the fact that industrywide exposures are so complex makes the determination of the active carcinogens difficult.
Since exposures within the industry are heterogeneous, attention should be focused on the possibility that there exist "hot spots" of high risk whereby a relatively small cohort of workers contributes disproportionately to the average risk. This may be the case for welders of stainless steels, a stable and identifiable group comprising about 10-15% of the total welding population, who are exposed to fumes containing about 5-10% Cr-30-90% of which is in the form of Cr(VI)-a substance absent in low alloy steels. A typical stainless steel welding cohort has a cumulative exposure to Cr(VI) of 5 mg/m3 (years) (1, 11) comparable to that of workers in the chromate industry (12) , where Cr(VI) is a putative carcinogen (13) .
The requirements on cohort size, cumulative exposure and latency-which must be satisfied in order to generate an epidemiological study of sufficient power to detect a statistically significant overincidence of respiratory tract cancer-makes studies of stainless steel welders prohibitive in most countries. If it could be demonstrated that occupational exposures of stainless steel welders and of chromate industry workers are biologically equivalent and result in equivalent human risk, then, based on the known risk for the chromate industry, the entire excess respiratory cancer risk for all welders could be assigned to this small subcohort which have been included in the previous studies of the general welding populations.
A preliminary attempt to demonstrate the human risk equivalence of stainless steel welding fumes could be based on comparative studies of the in vitro and in vivo genotoxicity of welding fumes and various solubility fractions thereof. The in vivo transplacental mutagenicity of MMA/SS fumes in the mouse spot test (Fleckentest) has been shown to be equivalent to that of the Cr(VI) content, as compared to that from Na2Cr2O7 (14, 15) . The quantitative response of sister chromatid exchange (SCE) for mammalian cells in culture to MIG/SS fumes (16, 17) has been shown to be due to the water-soluble Cr(VI) content and is equivalent to that of comparable amounts of dichromate; MMA/SS fumes produce a response which is significantly below that expected from their Cr(VI) content. Both serum and water-soluble fractions of Ni, obtained from fume composed of mixtures of Ni and NiO, induce specific (molar) SCE rates in human peripheral lymphocytes comparable with that produced by NiSO, (18) . This Ni; NiO fume shows, in the BHK cell-transformation test at equitoxic doses, a transformation potency equal to that of Ni3S2 and Ni(CH3COO)2 (19) . This fume has a tumorigenic potency in rats equal to that of NiS (20) .
In order to further develop the methodology of risk equivalence studies, it is necessary to examine some of the details of individual bioassay systems and to insure that collection, analysis and interpretation of the results are appropriate for the actual occupational situations for which comparison is intended. The results of some initial efforts in this direction are described below.
Materials and Methods

Production of Welding Fumes
A welding robot is used to produce a standard reference welding fume under well-controlled, reproducible conditions (21, 22 
Collection of Welding Fumes
Fumes are collected either by means of a 0.3 m diameter paper filter placed at the top of the column (Whatman #41) (the presence of which reduces the column flow by a factor of 6 with no fume loading), or by means of a special impinger system, followed by a total filter (Millipore 0.2 ,u) shown schematically in Figure 1 . For convenience, a single impinger can be used, although its efficiency for welding fumes is limited to below approximately 60%. To increase collection efficiency, and to mimic the human respiratory tract, two impingers can be run in series: aggregation of the fume in the 100% humidity of the first impinger results in a conditioning which increases the collection efficiency of the second impinger compared to the first. A parallel filter with the same flow is used to monitor the aerosol passing through the impinger system. 
Bioassay of Welding Fumes
The mutagenicity of welding fumes was studied using S. typhimurium tester strain TA 100 in the histidine revertant plate incorporation test of Ames following standard procedures (24) in the absence of a metabolizing system. In addition, a growing suspension of TA 100 is placed in the (single) impinger system, in order to study the mutagenicity of fresh fume. In this assay, aliquots are removed periodically during collection, half of each to be used for a determination of mutagenicity in minimal agar and half for a measurement of the corresponding survival rate.
Results and Discussion
The results of a large number of studies of the response of TA 100 to various fractions of welding fumes have recently been analyzed (25) . The The behavior of Cr(VI) in the various fume matrices with time is shown in Figure 3 . Although MMA/SS fume is stable, there is a reduction of Cr(VI) to Cr(III) due to the presence of Fe(II) in the MIG/SS matrix (27) . The Cr(VI) content at short times can be established only with the help of the impinger system. Some preliminary results are listed in Table 1 . It can be seen that up to 25% of the total Cr is in the form of Cr(VI) shortly after welding. Reduction in Cr(VI) content can also be followed as the fume rises in the collection manifold by withdrawing the aerosol at different points.
Since it is apparent that welding fume contains a short-lived mutagen, it is of interest to develop the in vitro bioassay so as to permit a determination of the mutagenic activity of fresh fumes, at a time comparable to that of inhalation. It is found that a growing suspension of TA 100 can be placed in the (single) impinger system, which then serves as a useful device for monitoring specific mutagenicity in fumes, from one second onward after welding (28) .
Welding can be performed almost continuously with the robot: a series of six beads, each of 180 sec duration, can be run on a single plate, which can be changed in 2-3 min. Figure 4 shows the results of a preliminary impinger run using the same MIG/SS welding wire used in the previous experiments, at a choice of the welding parameters (short arc, 17 V, 185 A) which gives essentially maximum Cr(VI) production (27) . Although the number of revertants obtained from each aliquot shows a maximum versus fume dose, the number of survivors falls continuously during the run to an ultimate level of the order of 10% of the initial count, leading to an approximtely linear dose-revertants/survivor response.
These studies have reinforced the conclusions that the active mutagen for TA 100 found in welding fumes is Cr(VI) and that this material, at least in the MIG/SS fume matrix, behaves identically as does Cr(VI) from other sources, in this bioassay system. In terms of support for the concept of equivalence of risk, there is evidence that, on an equal dose basis, Cr(VI) in welding fumes has the same biological effect as does Cr(VI) from other sources, and there is no reason to assume that the risk in the welding industry is mitigated, based on the observations to date.
On the other hand the specific activity of Cr(VI) from the MMA/SS matrix is reduced by a factor of 2-4, indicating some interference with the bioassay due to the presence of the other soluble substances present in the matrix. If the reduced activity could be shown to be due to a true antisynergistic effect, then it might be worthwhile to pursue this line of investigation to effect a simple genotoxic risk reduction.
The fact that Cr(VI) is found to decay rapidly in one fume matrix indicates that there is a serious underreporting of the occupational exposure to this substance under certain conditions [here the presence of a reducing agent, Fe(II)]. Presumably this is true of other mutagens, and any attempt to measure "risk equivalence" by in vitro (or in vivo) techniques must include the possibility of performing an assay of the actual work place exposures, and not only of grab samples returned to the laboratory for analysis at some later time.
Although the Ames assay with S. typhimurium is most probably not appropriate for most metals (29) because of its lack of sensitivity to lipid peroxidation and covalent bonding, it has been convenient for use as a tool to study Cr(VI) and to permit an assessment of the techniques for exposure, collection and analysis of a system about which a great deal is known. The observation of "false" Cr(VI) induced revertants in this system does not affect the conclusions of this article but does restrict the validity of the results to low Cr(VI) doses. The results of other studies in the program of in vitro determination of risk equivalence are presented in several concurrent articles (19, 26, 30 
